From: The roles of predictors in cardiovascular risk models - a question of modeling culture?
 | Test set (n = 514,661) | |
---|---|---|
Men (n = 237,748; 46.2%) | Women (n = 276,913; 53.8%) | |
Age (years) | 49.9 (11.9) | 50.1 (12.2) |
Total cholesterol (mg/dl) | 210 (41.9) | 212 (41.6) |
HDL cholesterol (mg/dl) | 51.4 (14.9) | 63.9 (17.2) |
Cholesterol ratio (total cholesterol/HDL cholesterol) | 4.38 (1.43) | 3.54 (1.14) |
Triglycerides (mg/dl) | 146 (94.6) | 108 (62.3) |
Blood glucose (mg/dl) | 98.3 (24.7) | 92.7 (20.4) |
Systolic BP (mmHg) | 133 (17.3) | 127 (18.7) |
Diastolic BP (mmHg) | 82.7 (10.1) | 79.6 (10.4) |
BP classes | ||
 Ideal | 25,964 (11.0%) | 67,687 (24.4%) |
 Normal | 59,743 (25.1%) | 74,538 (26.9%) |
 Still normal | 55,766 (23.5%) | 52,224 (18.9%) |
 Hypertension stage 1 | 56,417 (23.7%) | 45,370 (16.4%) |
 Hypertension stage 2 | 7200 (3.0%) | 6264 (2.3%) |
 Isolated systolic hypertension | 32,658 (13.7%) | 30,830 (11.1%) |
Hypertensive drug intake | ||
 Yes (vs. no) | 32,731 (13.8%) | 34,987 (12.6%) |
Smoking status | ||
 Yes (vs. no) | 59,279 (24.9%) | 58,164 (21.0%) |
Diabetes | ||
 Yes (vs. no) | 13,688 (5.8%) | 11,006 (4.0%) |
BMI score (kg/m2) | 27.4 (4.69) | 26.0 (5.68) |
BMI classes | ||
 < 18.5 | 866 (0.4%) | 6546 (2.4%) |
 18.5–24.9 | 75,942 (31.9%) | 136,837 (49.4%) |
 25.0–29.9 | 108,615 (45.7%) | 78,301 (28.3%) |
 30.0–34.9 | 37,675 (15.8%) | 34,310 (12.4%) |
 35.0–39.9 | 8229 (3.5%) | 11,454 (4.1%) |
 ≥ 40.0 | 6421 (2.7%) | 9465 (3.4%) |
Waist circumference | ||
 Too large (vs. okay) | 83,503 (35.1%) | 96,416 (34.8%) |
Physical activity | ||
 None | 26,347 (11.1%) | 31,161 (11.3%) |
 Ocassionally | 101,706 (42.8%) | 118,890 (42.9%) |
 Regularly | 109,695 (46.1%) | 126,862 (45.8%) |
Protein in urine | ||
 Positive (vs. negative) | 14,403 (6.1%) | 16,267 (5.9%) |
Glucose in urine | ||
 Positive (vs. negative) | 5481 (2.3%) | 4294 (1.6%) |